Squarepoint’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-153,465
Closed -$936K 3704
2021
Q3
$936K Buy
153,465
+55,793
+57% +$348K 0.01% 1603
2021
Q2
$804K Buy
97,672
+50,049
+105% +$426K 0.01% 1796
2021
Q1
$426K Buy
47,623
+30,671
+181% +$352K ﹤0.01% 2145
2020
Q4
$196K Sell
16,952
-63,289
-79% -$735K ﹤0.01% 2525
2020
Q3
$835K Buy
80,241
+19,086
+31% +$234K 0.01% 1086
2020
Q2
$804K Buy
61,155
+20,112
+49% +$209K 0.01% 1062
2020
Q1
$323K Buy
41,043
+1,987
+5% +$29.9K 0.01% 1267
2019
Q4
$808K Buy
+39,056
New +$659K ﹤0.01% 1466
2019
Q3
Sell
-35,071
Closed -$431K 2806
2019
Q2
$431K Sell
35,071
-856
-2% -$9.88K ﹤0.01% 1751
2019
Q1
$448K Buy
35,927
+23,144
+181% +$309K ﹤0.01% 1545
2018
Q4
$145K Sell
12,783
-35,043
-73% -$549K ﹤0.01% 1757
2018
Q3
$895K Sell
47,826
-22,876
-32% -$526K 0.01% 1043
2018
Q2
$1.83M Buy
70,702
+50,172
+244% +$1.3M 0.02% 672
2018
Q1
$460K Buy
+20,530
New +$501K 0.01% 1125
2017
Q4
Sell
-12,325
Closed -$298K 2424
2017
Q3
$298K Buy
+12,325
New +$290K 0.01% 1188
2017
Q1
Sell
-47,033
Closed -$895K 2054
2016
Q4
$895K Buy
+47,033
New +$899K 0.04% 554
2016
Q3
Sell
-24,500
Closed -$367K 1352
2016
Q2
$367K Buy
+24,500
New +$308K 0.02% 657